Physician profile
Rony N Lahoud
NPI 1659534212
$99,251.44
in general payments reported to CMS, 2019-2025
6 companies · $54K in 2025
The $54K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2021: $14.00 · 2022: $1,500 · 2023: $16K · 2024: $26K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Travel and Lodging: $14K · Consulting Fee: $3,375 · Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,880.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,575.00 |
| Travel and Lodging | $13,930.08 |
| Consulting Fee | $3,375.00 |
| Food and Beverage | $1,554.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $59,426.19 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $32,030.99 | 2025 | Mitraclip, Triclip, Dragonfly Opstar |
| Edwards Lifesciences Corporation | $6,357.69 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Boston Scientific Corporation | $1,422.57 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.00 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rony Lahoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.